A complete application in a minute — tailored resume and cover letter, ready to send.
ICON Clinical Research Ltd. is seeking an Investigator Payments Coordinator in Dublin for a hybrid role, with a focus on accurate, timely payments to clinical trial investigators.
The role requires prior payment experience and CRO familiarity to support cross-functional teams across contracts, accounts payable, and clinical operations. The ideal candidate will have a finance-related degree and 2+ years of investigator payments exposure, leveraging advanced Excel to manage complex payment
Investigator Payments Coordinator - Dublin based (hybrid role)- Must have payment experience and Clinical Trials (CRO) experience
ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster. As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers. We are currently seeking an Investigator Payments Coordinator to join our diverse and dynamic team. As an Investigator Payments Coordinator at ICON, you will play a key role in managing and processing payments to clinical trial investigators, ensuring accuracy and timeliness in financial transactions. You will collaborate with internal teams and external partners to support the financial aspects of clinical trials, contributing to smooth operations and effective investigator engagement.
Employment with ICON is contingent upon having the legal right to work in the country where the role is based.
Benefits may include:
Benefits may vary depending on role and location.
Visit our careers site to read more about the benefits ICON offers.
ICON is an equal opportunity employer.
We are committed to building an inclusive and accessible workplace where everyone feels valued and supported.
If you require reasonable accommodations during the recruitment process, please let us know or submit a request here.